2nd Quarter - Report
INVARIANT LLC for ANTHEIA
Firm
Client
Income
$60,000
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Highlight Antheia's use of synthetic biology to produce active pharmaceutical ingredients, support initiatives that expand domestic production capabilities of API, and educate lawmakers on various solutions to enhance drug supply chain resiliency.
| Lobbyist | Covered position, as disclosed |
|---|---|
| CHRISTOPHER GILLOTT | — |
| JESSICA HATCHER | — |
| BENJAMIN KLEIN New | Legislative Director, Senator Byron Dorgan (2007-2010); Legislative Assistant, Senator Byron Dorgan (2005-2007) |
| KATHRYN WISE | — |
Defense DEF
Encourage support for the domestic manufacturing of active pharmaceutical ingredients.
| Lobbyist | Covered position, as disclosed |
|---|---|
| CHRISTOPHER GILLOTT | — |
| JESSICA HATCHER | — |
| BENJAMIN KLEIN New | Legislative Director, Senator Byron Dorgan (2007-2010); Legislative Assistant, Senator Byron Dorgan (2005-2007) |
| KATHRYN WISE | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.